ArticleBlood2018

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.

Edit Porpaczy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.